Comparison of the Efficacy of Mifepristone and Marvelon Treatment for Perimenopausal Dysfunctional Uterine Bleeding
Abstract
Objective: To investigate the efficacy of mifepristone and Marvelon treatment for perimenopausal dysfunctional uterine bleeding. Method: 60 patients were randomly selected from January 2016 to June 2016 in our hospital for treatment of menopausal gouthenopsis. After different treatment regimens were communicated with the patients, the patients were treated with different methods. In the experimental group (28 cases), mifepristone was used to treat dysfunctional uterine bleeding. The control group (32 cases) was treated with Marvelon treatment and the results were compared between the two groups. Results: The initial conditions of the two groups were not significantly different (P > 0.05), seen from the levels of folliclein, luteinizing hormone, estrogen and progesterone. After treatment however, the effective rate of the treatment group was significantly higher than the control group (P < 0.05). Conclusion: Mifepristone is effective in the treatment of perimenopausal dysfunction.
References
Liang Huihong, Zhang Qixin, Liu Tingting, et al. Mifepristone Intermittent Therapy and Continuous Medication in the Treatment of Perimenopausal Dysfunctional Uterine Bleeding Comparison. Heilongjiang Medical, 2013, 37 (10): 960-961.
Li Huashu, Wang Qingjin, Pan Xuhua, et al. Comparison of the Efficacy of Mirex and Mifepristone in the Treatment of Perimenopausal Dysfunctional Uterine Bleeding. Chinese General Practice, 2013,11 (8): 1211-1212,1270.
Weisberg E, Hickey M, Palmer D, et al. A Pilot Study to Assess the Effect of Three Short-Term Treatment on Frequent and /or Prolong Edbleeding Compared To Placebo in Women Using Implanon [J] .Human Reproduction, 2006,21 (1): 295-302.
Huang Yanhong, Wang Jianmin, et al. Hysteroscopy Endometrial Resection Combined with Mifepristone in Perimenopausal Dysfunctional Uterine Bleeding in the Recent Efficacy of Chinese Medicine Innovation, 2011, 8 (2): 59-61.
Copyright (c) 2017 Xiaopin Yang
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors contributing to this journal agree to publish their articles under the Creative Commons Attribution-Noncommercial 4.0 International License, allowing third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit, that the work is not used for commercial purposes, and that in the event of reuse or distribution, the terms of this license are made clear. With this license, the authors hold the copyright without restrictions and are allowed to retain publishing rights without restrictions as long as this journal is the original publisher of the articles.
